Real-time enrollment status for this fatty liver disease clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:30 PM UTC
| NCT Number | NCT07165028 |
| Recruiting Status | Recruiting |
| Condition | Fatty Liver Disease |
| Phase | PHASE3 |
| Target Enrollment | 4,500 participants |
| Active Locations | 142 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07165028 is currently recruiting participants. This phase3 study for fatty liver disease is actively seeking new participants at 142 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07165028 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 142 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07165028 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.